153 related articles for article (PubMed ID: 8232064)
1. Felbamate.
Med Lett Drugs Ther; 1993 Nov; 35(910):107-9. PubMed ID: 8232064
[No Abstract] [Full Text] [Related]
2. Felbamate: a new antiepileptic drug.
Brodie MJ
Lancet; 1993 Jun; 341(8858):1445-6. PubMed ID: 8099147
[No Abstract] [Full Text] [Related]
3. Felbamate.
Sofia RD; Kramer L; Perhach JL; Rosenberg A
Epilepsy Res Suppl; 1991; 3():103-8. PubMed ID: 1777064
[No Abstract] [Full Text] [Related]
4. [Therapeutic drug monitoring of felbamate].
Tribut O; Bentué-Ferrer D; Verdier MC;
Therapie; 2010; 65(1):35-8. PubMed ID: 20205993
[TBL] [Abstract][Full Text] [Related]
5. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
Palmer KJ; McTavish D
Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
[TBL] [Abstract][Full Text] [Related]
6. Felbamate.
Leppik IE
Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
[TBL] [Abstract][Full Text] [Related]
7. Involuntary movement disorders associated with felbamate.
Kerrick JM; Kelley BJ; Maister BH; Graves NM; Leppik IE
Neurology; 1995 Jan; 45(1):185-7. PubMed ID: 7824115
[TBL] [Abstract][Full Text] [Related]
8. Felbamate.
Bourgeois BF
Semin Pediatr Neurol; 1997 Mar; 4(1):3-8. PubMed ID: 9097361
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric side effects related to treatment with felbamate.
McConnell H; Snyder PJ; Duffy JD; Weilburg J; Valeriano J; Brillman J; Cress K; Cavalier J
J Neuropsychiatry Clin Neurosci; 1996; 8(3):341-6. PubMed ID: 8854308
[TBL] [Abstract][Full Text] [Related]
10. Felbamate: clinical and molecular aspects of a unique antiepileptic drug.
Brown WM; Aiken SP
Crit Rev Neurobiol; 1998; 12(3):205-22. PubMed ID: 9847055
[TBL] [Abstract][Full Text] [Related]
11. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
Steinhoff BJ
Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
[TBL] [Abstract][Full Text] [Related]
12. Felbamate therapy in the Lennox-Gastaut syndrome.
Snodgrass SR
N Engl J Med; 1993 Jun; 328(22):1641. PubMed ID: 8487814
[No Abstract] [Full Text] [Related]
13. Felbamate (Felbatol).
Sorensen SJ; Farrington E
Pediatr Nurs; 1993; 19(6):630-2, 634. PubMed ID: 8278240
[No Abstract] [Full Text] [Related]
14. Felbamate: 1997 update.
Pellock JM; Brodie MJ
Epilepsia; 1997 Dec; 38(12):1261-4. PubMed ID: 9578519
[No Abstract] [Full Text] [Related]
15. New antiepilepsy drug, felbamate, marketed.
Clin Pharm; 1993 Oct; 12(10):713. PubMed ID: 8258253
[No Abstract] [Full Text] [Related]
16. Is there any future for felbamate treatment?
Borowicz KK; Piskorska B; Kimber-Trojnar Z; Małek R; Sobieszek G; Czuczwar SJ
Pol J Pharmacol; 2004; 56(3):289-94. PubMed ID: 15215558
[TBL] [Abstract][Full Text] [Related]
17. [New antiepileptic drugs: vagabatrin, lamotrigine and felbamate].
Herranz JL; Arteaga R; Armijo JA
Neurologia; 1994 Nov; 9(9):410-7. PubMed ID: 7811493
[No Abstract] [Full Text] [Related]
18. Felbamate: successful development of a new compound for the treatment of epilepsy.
Schmidt D
Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
[TBL] [Abstract][Full Text] [Related]
20. Psychosis associated with felbamate treatment.
Knable MB; Rickler K
J Clin Psychopharmacol; 1995 Aug; 15(4):292-3. PubMed ID: 7593718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
